Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFaron Pharmaceuticals Share News (FARN)

Share Price Information for Faron Pharmaceuticals (FARN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 177.50
Bid: 170.00
Ask: 185.00
Change: 0.00 (0.00%)
Spread: 15.00 (8.824%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 177.50
FARN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK Earnings, Trading Statements Calendar - Next 7 Days

Thu, 06th Sep 2018 16:01

Friday 7 September 
Secure Income REITHalf Year Results 
Ashmore GroupFull Year Results 
EnquestHalf Year Results 
Greene KingTrading Statement 
Pacific Horizon Investment Trust Full Year Results 
Monday 10 September 
AbcamFull Year Results
Associated British FoodsTrading Statement 
HGCapital TrustHalf Year Results
Gulf Keystone PetroleumHalf Year Results 
BradyHalf Year Results 
Tuesday 11 September 
Ashtead GroupQ1 Results
JD Sports FashionHalf Year Results
Sanne GroupHalf Year Results
Midwich GroupHalf Year Results
Alumasc GroupFull Year Results
Vectura GroupHalf Year Results
Cairn EnergyHalf Year Results
Hilton FoodHalf Year Results
HarworthHalf Year Results
EU SupplyHalf Year Results
DP EurasiaHalf Year Results
Puretech HealthHalf Year Results
Surgical InnovationsHalf Year Results
Silence TherapeuticsHalf Year Results
Wednesday 12 September 
Galliford TryFull Year Results 
Property FranchiseHalf Year Results
iGas EnergyHalf Year Results
1pmHalf Year Results
Epwin GroupHalf Year Results
Ten EntertainmentHalf Year Results
Futura MedicalHalf Year Results
Dunelm GroupFull Year Results 
WilmingtonFull Year Results 
Medica GroupHalf Year Results
Safestore HoldingsQ3 Results
Charles TaylorHalf Year Results
Advanced Medical Solutions GroupHalf Year Results
Thursday 13 September 
GVC HoldingsHalf Year Results
WM Morrison SupermarketsHalf Year Results
Faron PharmaHalf Year Results
Oxford BiomedicaHalf Year Results
BiffaTrading Statement
Ophir EnergyHalf Year Results
RicardoFull Year Results 
Xeros TechnologyHalf Year Results
  

More News
9 Mar 2020 14:07

Faron Pharmaceuticals Gets Green Light For New Traumakine Trial

Faron Pharmaceuticals Gets Green Light For New Traumakine Trial

Read more
9 Mar 2020 10:26

Faron gets FDA tick from proposed design of next 'Traumakine' study

(Sharecast News) - Faron Pharmaceuticals announced on Monday that the US Food and Drug Administration (FDA) has accepted its proposed protocol design for the next 'Traumakine' study in acute respiratory distress syndrome (ARDS) patients, following its protocol submission in February.

Read more
5 Mar 2020 14:28

Faron Pharmaceuticals "Encouraged" After Latest Matins Trial Findings

Faron Pharmaceuticals "Encouraged" After Latest Matins Trial Findings

Read more
2 Mar 2020 12:04

Faron Pharmaceuticals Buys Rights For AOC3 Antagonist Platform

Faron Pharmaceuticals Buys Rights For AOC3 Antagonist Platform

Read more
2 Mar 2020 10:08

Faron Pharmaceuticals acquires rights to AOC3 inhibitors

(Sharecast News) - Clinical stage biopharmaceutical company Faron Pharmaceuticals has acquired rights for the potential new use of AOC3 inhibitors covered by a recently filed patent application.

Read more
6 Feb 2020 14:17

Faron Pharmaceuticals Alters Traumakine Study After US FDA Feedback

Faron Pharmaceuticals Alters Traumakine Study After US FDA Feedback

Read more
27 Jan 2020 11:22

Faron Pharma To Test Clevegen In Patients With Ovarian Cancer

Faron Pharma To Test Clevegen In Patients With Ovarian Cancer

Read more
13 Jan 2020 11:54

Faron Pharma Gets Approval For Part II Trial Of Clevegen Drug

Faron Pharma Gets Approval For Part II Trial Of Clevegen Drug

Read more
30 Dec 2019 15:39

Faron Pharma requests arbitration over Traumakine manufacturing deal

(Sharecast News) - Clinical-stage biopharmaceutical company Faron Pharmaceuticals announced on Monday that, further to the update on 'Traumakine' drug substance manufacturing on 2 October, it has carried out a detailed investigation into the circumstances around manufacturing arrangements.

Read more
30 Dec 2019 10:56

Faron Pharma Files For Arbitration Amid Traumakine Deal Termination

Faron Pharma Files For Arbitration Amid Traumakine Deal Termination

Read more
11 Dec 2019 13:42

Faron Pharmaceuticals upbeat on new data from 'MATINS' study

(Sharecast News) - Clinical stage biopharmaceutical company Faron Pharmaceuticals announced new data from 'MATINS'-trial patients on Wednesday, to be presented at the ESMO Immuno-Oncology Congress 2019 in Geneva.

Read more
11 Dec 2019 10:45

Faron Pharmaceuticals Pleased With Clevegen Clinical Trial Performance

Faron Pharmaceuticals Pleased With Clevegen Clinical Trial Performance

Read more
29 Nov 2019 10:23

Faron Pharmaceuticals Inks Share Liquidity Pact With Lago Kapital

Faron Pharmaceuticals Inks Share Liquidity Pact With Lago Kapital

Read more
28 Nov 2019 11:56

Faron Pharmaceuticals Says US Regulator Approves Clevegen Drug Status

Faron Pharmaceuticals Says US Regulator Approves Clevegen Drug Status

Read more
21 Nov 2019 12:56

Faron Pharmaceuticals Applies For Nasdaq First North Growth Listing

Faron Pharmaceuticals Applies For Nasdaq First North Growth Listing

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.